本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Viking Therapeutics, Inc.

32.01
-0.0600-0.19%
盘后32.200.1900+0.59%19:59 EDT
成交量:339.45万
成交额:1.09亿
市值:35.95亿
市盈率:-27.76
高:33.16
开:32.16
低:31.28
收:32.07
数据加载中...
2021/04/08

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/02/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/06

重要事件披露

8-K - Current report
2020/10/28

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/28

重要事件披露

8-K - Current report
2020/08/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/29

重要事件披露

8-K - Current report
2020/05/21

重要事件披露

8-K - Current report
2020/04/30

重要事件披露

8-K - Current report
2020/04/30

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/03/17

重要事件披露

Current report, item 7.01
2020/02/26

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/26

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals